Biotech Holdings
Biotech Holdings private placement funding to be applied to diabetes drug launch
Published in Medical Verdicts and Law Weekly, November 25th, 2004
"These funds will be applied to requirements associated with the launch of our diabetes drug, Sucanon, in Mexico including purchase of television and radio time, in-store support for Sucanon and medical presentations," Rieveley said.
"We have to date received $111,000 of the above private placement funding. Shares pursuant to this funding will be issued at $.50 Cdn, with each share having a 2-year warrant exercisable at CDN $0.55. The U.S....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Aastrom Biosciences, Inc.
Diabetic limb ischemia clinical trial agreement signed - Abortion
Abortion clinic says it will not require parental consent - Abortion
Challenge to Oklahoma's parental notification law thrown out - Cellerant Therapeutics, Inc.
European patent office grants broad claims on the human hematopoietic stem cell - Centers for Medicare & Medicaid Services
Payment rates and policy changes announced for hospital outpatient services - Coalition for Affordable and Reliable Healthcare
New report lauded as evidence that medical malpractice reform works - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
